Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up
Nat Commun
.
2023 Mar 22;14(1):1593.
doi: 10.1038/s41467-023-37338-7.
Authors
Michal Canetti
1
2
,
Noam Barda
3
4
5
,
Mayan Gilboa
1
2
,
Victoria Indenbaum
2
6
,
Michal Mandelboim
2
6
,
Tal Gonen
1
2
,
Keren Asraf
2
7
,
Yael Weiss-Ottolenghi
1
2
,
Sharon Amit
2
8
,
Ram Doolman
2
7
,
Ella Mendelson
2
6
,
Dror Harats
9
,
Laurence S Freedman
10
,
Yitshak Kreiss
2
9
,
Yaniv Lustig
2
6
11
,
Gili Regev-Yochay
12
13
Affiliations
1
The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
2
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
3
ARC Innovation Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
4
Software and Information Systems Engineering, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
5
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
6
Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
7
The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
8
Clinical Microbiology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
9
General Management, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
10
Biostatistics and Biomathematics Unit, Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel.
11
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
12
The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
[email protected]
.
13
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
[email protected]
.
PMID:
36949080
PMCID:
PMC10032242
DOI:
10.1038/s41467-023-37338-7
No abstract available
Publication types
Published Erratum